The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
319last 24h
2133last 7d
379● bullish (7d)
186● bearish (7d)
204publishers
Simply Wall St.29d agobearish
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review ExpandsMT Newswires29d agobearish
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se
MT Newswires29d agobearish
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev(Update with the Justice Department's response to a request for comment in the third paragraph.)
Healthcare Dive43d agobearish
Court dismisses PBMs’ lawsuit against FTC following insulin settlementsExpress Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.